Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
J. Bellmunt
Based on 18 articles published since 2007
||||
Expertise Level
The expertise of J. Bellmunt ranks in the Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Medical Oncology, Hospital del Mar-IMIM Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Netherlands Cancer Institute/AvL St Antonius Ziekenhuis, Nieuwegein, The Netherlands. · Medical Oncology, Hospital General Universitario de Elche, Elche, Alicante. · Medical Oncology, Vall d´Hebron University Hospital, Vall d´ Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Medical Oncology, Hospital Ramón y Cajal, Madrid. · Medical Oncology, Centro Oncológico de Galicia, Galicia. · Oncology, Hospital Son Llàtzer, Palma Di Mallorca. · Medical Oncology, Fundación Jiménez Díaz, Madrid. · Medical Oncology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. · Medical Oncology, Complejo Hospitalario Universitario Ourense, Ourense. · Medical Oncology, Hospital General Universitario Morales Meseguer-IMIB-UCAM, Murcia, Spain. · Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Medical Oncology, Hospital Lozano Blesa, Zaragoza. · Oncology, Clínica Universidad de Navarra, Pamplona. · Medical Oncology, Hospital Clínico San Carlos, Madrid. · Medical Oncology, Hospital San Pedro Alcántara, Cáceres, Spain. · Internal Medicine, St. Antonius Ziekenhuis Hospital, Nieuwegein, The Netherlands. · Medical Department, Pivotal CRO, Madrid, Spain. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28419193
2016
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · UAB Comprehensive Cancer Center, Birmingham. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy · Pubmed 26487582
  • Ludwig Boltzmann Institute for ACR VIEnna/LB-CTO ACR-ITR VIEnna, KFJ-Spital, Vienna, Austria Cancer Research Centre, University of Warwick, Coventry, UK · Oncology Institute, Instytut im Sklodowskiej-Curie, Warsaw, Poland. · Dana-Farber Cancer Institute-Harvard Medical School, Boston, USA. · Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France. · Department of Internal Medicine, National Cheng Kung University Hospital, Taipei, Taiwan. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Department of Medicine, Centre Léon Bérard, Lyon. · Department of Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Urology, KH Barmherzige Schwestern Linz, Linz, Austria. · Department of Urology, University Hospital Rechts Der Isar, Munich, Germany. · Department of Medical Oncology, Hopital Saint-Louis-APHP, Paris-Diderot University, Paris, France. · Pubmed 26673352
2015
  • Department of Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · University of Massachusetts Medical School, Worcester, MA 01655, USA. · Department of Urology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · 1] Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA 02215, USA [2] Division of Urology, Brigham and Women's Hospital, Boston, MA 02215, USA. · Department of Pathology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 25535728
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2013
  • Bladder Cancer Center at the Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, 1230 DANA, Boston, MA 02215, USA. · Pubmed 24129239
Probable:    Hospital del Mar      
2017
  • Medical Oncology, Hospital del Mar-IMIM Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Netherlands Cancer Institute/AvL St Antonius Ziekenhuis, Nieuwegein, The Netherlands. · Medical Oncology, Hospital General Universitario de Elche, Elche, Alicante. · Medical Oncology, Vall d´Hebron University Hospital, Vall d´ Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Medical Oncology, Hospital Ramón y Cajal, Madrid. · Medical Oncology, Centro Oncológico de Galicia, Galicia. · Oncology, Hospital Son Llàtzer, Palma Di Mallorca. · Medical Oncology, Fundación Jiménez Díaz, Madrid. · Medical Oncology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. · Medical Oncology, Complejo Hospitalario Universitario Ourense, Ourense. · Medical Oncology, Hospital General Universitario Morales Meseguer-IMIB-UCAM, Murcia, Spain. · Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Medical Oncology, Hospital Lozano Blesa, Zaragoza. · Oncology, Clínica Universidad de Navarra, Pamplona. · Medical Oncology, Hospital Clínico San Carlos, Madrid. · Medical Oncology, Hospital San Pedro Alcántara, Cáceres, Spain. · Internal Medicine, St. Antonius Ziekenhuis Hospital, Nieuwegein, The Netherlands. · Medical Department, Pivotal CRO, Madrid, Spain. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28419193
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2013
  • Department of Oncology, University Hospital del Mar-L'Institut Municipal d'Investigació Mèdica IMIM, Barcelona, Spain. · Pubmed 23419284
2011
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 21908503
2010
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 20555063
  • University Hospital del Mar, Barcelona, Spain. · Pubmed 20943643
2009
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 19454472
  • Medical Oncology Service, Hospital del Mar - IMAS, Experimental Cancer Therapeutics Unit (URTEC) IMIM-H del Mar, Barcelona, Spain. · Pubmed 18640849
2008
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 18456766
Probable:    Universitat Autonoma de Barcelona      
2007
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by J. Bellmunt about Urinary Bladder Neoplasms:

  • A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN). 2017
  • Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis. 2016
  • Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1). 2016
  • Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients. 2015
  • Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. 2014
  • The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine. 2013
  • Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. 2013
  • Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. 2013
  • Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2011
  • Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls. 2011
Show List of Full Article Records
Google Searches

Learn more about J. Bellmunt using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Hospital del Mar
Universitat Autonoma de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Medical Oncology, Hospital del Mar-IMIM Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Netherlands Cancer Institute/AvL St Antonius Ziekenhuis, Nieuwegein, The Netherlands. · Medical Oncology, Hospital General Universitario de Elche, Elche, Alicante. · Medical Oncology, Vall d´Hebron University Hospital, Vall d´ Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Medical Oncology, Hospital Ramón y Cajal, Madrid. · Medical Oncology, Centro Oncológico de Galicia, Galicia. · Oncology, Hospital Son Llàtzer, Palma Di Mallorca. · Medical Oncology, Fundación Jiménez Díaz, Madrid. · Medical Oncology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. · Medical Oncology, Complejo Hospitalario Universitario Ourense, Ourense. · Medical Oncology, Hospital General Universitario Morales Meseguer-IMIB-UCAM, Murcia, Spain. · Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Medical Oncology, Hospital Lozano Blesa, Zaragoza. · Oncology, Clínica Universidad de Navarra, Pamplona. · Medical Oncology, Hospital Clínico San Carlos, Madrid. · Medical Oncology, Hospital San Pedro Alcántara, Cáceres, Spain. · Internal Medicine, St. Antonius Ziekenhuis Hospital, Nieuwegein, The Netherlands. · Medical Department, Pivotal CRO, Madrid, Spain. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28419193
2016
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · UAB Comprehensive Cancer Center, Birmingham. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy · Pubmed 26487582
  • Ludwig Boltzmann Institute for ACR VIEnna/LB-CTO ACR-ITR VIEnna, KFJ-Spital, Vienna, Austria Cancer Research Centre, University of Warwick, Coventry, UK · Oncology Institute, Instytut im Sklodowskiej-Curie, Warsaw, Poland. · Dana-Farber Cancer Institute-Harvard Medical School, Boston, USA. · Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France. · Department of Internal Medicine, National Cheng Kung University Hospital, Taipei, Taiwan. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Department of Medicine, Centre Léon Bérard, Lyon. · Department of Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Urology, KH Barmherzige Schwestern Linz, Linz, Austria. · Department of Urology, University Hospital Rechts Der Isar, Munich, Germany. · Department of Medical Oncology, Hopital Saint-Louis-APHP, Paris-Diderot University, Paris, France. · Pubmed 26673352
2015
  • Department of Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · University of Massachusetts Medical School, Worcester, MA 01655, USA. · Department of Urology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · 1] Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA 02215, USA [2] Division of Urology, Brigham and Women's Hospital, Boston, MA 02215, USA. · Department of Pathology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 25535728
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2013
  • Bladder Cancer Center at the Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, 1230 DANA, Boston, MA 02215, USA. · Pubmed 24129239
Hospital del Mar
2017
  • Medical Oncology, Hospital del Mar-IMIM Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Netherlands Cancer Institute/AvL St Antonius Ziekenhuis, Nieuwegein, The Netherlands. · Medical Oncology, Hospital General Universitario de Elche, Elche, Alicante. · Medical Oncology, Vall d´Hebron University Hospital, Vall d´ Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Medical Oncology, Hospital Ramón y Cajal, Madrid. · Medical Oncology, Centro Oncológico de Galicia, Galicia. · Oncology, Hospital Son Llàtzer, Palma Di Mallorca. · Medical Oncology, Fundación Jiménez Díaz, Madrid. · Medical Oncology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. · Medical Oncology, Complejo Hospitalario Universitario Ourense, Ourense. · Medical Oncology, Hospital General Universitario Morales Meseguer-IMIB-UCAM, Murcia, Spain. · Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Medical Oncology, Hospital Lozano Blesa, Zaragoza. · Oncology, Clínica Universidad de Navarra, Pamplona. · Medical Oncology, Hospital Clínico San Carlos, Madrid. · Medical Oncology, Hospital San Pedro Alcántara, Cáceres, Spain. · Internal Medicine, St. Antonius Ziekenhuis Hospital, Nieuwegein, The Netherlands. · Medical Department, Pivotal CRO, Madrid, Spain. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28419193
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2013
  • Department of Oncology, University Hospital del Mar-L'Institut Municipal d'Investigació Mèdica IMIM, Barcelona, Spain. · Pubmed 23419284
2011
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 21908503
2010
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 20555063
  • University Hospital del Mar, Barcelona, Spain. · Pubmed 20943643
2009
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 19454472
  • Medical Oncology Service, Hospital del Mar - IMAS, Experimental Cancer Therapeutics Unit (URTEC) IMIM-H del Mar, Barcelona, Spain. · Pubmed 18640849
2008
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 18456766
Universitat Autonoma de Barcelona
2007
3 Other Locations Show
Yearly article counts 012113022222
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.